ClinicalTrials.Veeva

Menu

Comparison of Lateralized RTSA With and Without Subscapularis Repair

P

Panam Clinic

Status and phase

Enrolling
Early Phase 1

Conditions

Arthritis Shoulder

Treatments

Procedure: RTSA without subscapularis repair
Procedure: RTSA with subscapularis repair

Study type

Interventional

Funder types

Other

Identifiers

NCT04728282
RSASUB-16-01-2021

Details and patient eligibility

About

The purpose of this double-blind randomized controlled trial is to compare patient-reported, clinical, and functional outcomes in patients undergoing RTSA with and without subscapularis repair after placement of a modern "lateralized" implant over the course of 24-months postoperative.

Full description

The main objective of this study is to compare patient-reported outcome measures (PROMs), and clinical and functional outcomes between RTSA with and without subscapularis repair. The specific aims for this study are:

Specific Aim 1:

To determine if there is a difference in PROM scores between RTSA with and without subscapularis repair during the 24-month postoperative period.

Specific Aim 2:

To determine if there is a difference between the two surgical approaches with respect to shoulder function, specifically range of motion and strength, during the 24-month postoperative period.

Specific Aim 3:

To determine if there is a difference in shoulder dislocation rates between RTSA with and without subscapularis repair during the 24-month postoperative period.

Specific Aim 4:

To determine if there is a difference in surgical complications, re-operation or revision rates between RTSA with and without subscapularis repair during the 24-month postoperative period.

Specific Aim 5:

To quantify the operative times for RTSA with and without subscapularis repair, and determine if there is a difference between the two approaches.

Enrollment

84 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of glenohumeral arthritis, rotator cuff arthropathy, or massive irreparable rotator cuff tear with surgeon-patient decision to undergo RTSA
  • First RTSA implantation
  • Absence of neoplastic diseases at the treated site
  • Fatty infiltration of the subscapularis is low-grade (i.e. Goutallier < Grade 3) based on pre-operative CT performed as standard of care in the patient group

Exclusion criteria

  • Previous shoulder arthroplasty (hemi-, total shoulder, or RTSA)
  • Avascular necrosis
  • Post-infectious arthritis
  • Proximal humerus fracture
  • Inflammatory arthritis
  • Inability to communicate in English
  • Unable to return for study visits to 24-months post-operative (e.g. unable to arrange transportation to study appointments, plans to relocate, etc.)

Intra-operative Exclusions:

  • Subscapularis with fatty infiltration (Goutallier ≥ 3)
  • Subscapularis that is deemed to be irreparable. An irreparable tendon is defined as one that is not of sufficient quality or does not allow adequate excursion to reach the repair site
  • Any anatomical or patient characteristic that warrants a non-lateralized implant

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

84 participants in 2 patient groups

RTSA with subscapularis repair
Experimental group
Treatment:
Procedure: RTSA with subscapularis repair
RTSA without subscapularis repair
Active Comparator group
Treatment:
Procedure: RTSA without subscapularis repair

Trial contacts and locations

1

Loading...

Central trial contact

Sheila McRae, PhD; Derek McLennan, BSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems